Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |